摘要
目的:对氟罗沙星和培氟沙星贯序治疗下呼吸道感染进行药物经济学分析,为临床提供用药参考.方法采用回顾性研究法,收集122例下呼吸道感染患者,分成两个治疗组:氟罗沙星组和培氟沙星组,采用统计研究和成本-效果分析方法对两治疗组进行药物经济学比较.结果氟罗沙星和培氟沙星贯序治疗下呼吸道感染总有效率分别为89.83%和87.30%,效果无显著差异(P>0.05);治疗成本分别为290.63元和236.07元,成本-效果比分别为3.23和2.70.结论与氟罗沙星相比,培氟沙星贯序治疗下呼吸道感染具有成本-效果优势.
Objective:To investigate the cost-effect of Fleroxacin and Pefloxacin for impenetrate treatment of lower respiratory infection. Methods:122 cases with lower respiratory infection are selected by retrospective analysis. They are divided into 2 groups and treated with Fleroxacin and Pefloxacin, respectively. The cost-effect of two groups is analyzed and compared with each other by the statistical method and cost-effectiveness analysis. Results:The effectiveness rates of Fleroxacin and Pefloxacin are 89.83%and 87.30% respectively, there is no statistically significant difference (P>0.05). The costs of two drugs are 290.63 and 36.07 yuan respectively; and their cost-efect ratios are 3.23 and 2.70, respectively. Conclusion:Pefloxacin has cost-effect advantage over Fleroxacin in the impenetrate treatment of lower respiratory infection.
出处
《西南民族大学学报（自然科学版）》
CAS
2009年第3期540-542,共3页
Journal of Southwest Minzu University(Natural Science Edition)
关键词
氟罗沙星
培氟沙星
下呼吸道感染
药物经济学
成本-效果分析
lower respiratory infection
Fleroxacin
Pefloxacin
pharmacoeconomics
cost-effectiveness analysis
